Skip to content

Clinical trials

Phase 1 Lymphoproliferative Disorders trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoproliferative Disorders Phase: Phase 1 Clear all

40 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20021
20032
20044
20053
20073
20084
20113
20121
20132
20141
20162
20172
20181
20191
20202
20243
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed21
Terminated5
Recruiting4
Active, not recruiting4
Withdrawn3
Unknown status2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Baylor College of Medicine6
Seagen Inc.4
Jonsson Comprehensive Cancer Center2
M.D. Anderson Cancer Center2
National Institute of Allergy and Infectious Diseases (NIAID)2
Nordic Nanovector2
UNC Lineberger Comprehensive Cancer Center2
AVEO Pharmaceuticals, Inc.1
Cancer Research UK1
Celularity Incorporated1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoproliferative Disorders40
Lymphoma18
Lymphoma, Non-Hodgkin15
Hodgkin Disease12
Immunoproliferative Disorders11
Lymphatic Diseases9
Neoplasms9
Burkitt Lymphoma8
Hematologic Diseases8
Leukemia, Lymphocytic, Chronic, B-Cell8

Trials

Showing 76 to 40 of 40. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.